Prevalence of Potential Drugs


The main purpose of this study is to evaluate the prevalence and explain the characteristics of PDDIs  in medical recommendation of hospitalized surgical patients. In this transverse study, we examine 370 medical prescriptions from the surgery unit of a Mexican public teaching hospital. The classification and identification of potential drug-drug interactions were performed with the Micromedex 2.0 electronic drug information database. Results were examined with illustrative statistics and we estimated OR (odds ratio) to determine associated risk factors.




 


  • Study of Medscape Drug Interaction Checker

Related Conference of Prevalence of Potential Drugs

July 25-26, 2024

34th Annual European Pharma Congress

Frankfurt, Germany
August 06-07, 2024

27th World Congress on Nursing, Pharmacology and Healthcare

Aix-en-Provence, France
August 28-29, 2024

4th International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
October 31-01, 2024

37th World Congress on Pharmacology

Amsterdam, Netherlands
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE
April 14-15, 2025

18th European Biosimilars Congress

Aix-en-Provence, France

Prevalence of Potential Drugs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in